Literature DB >> 3047875

Cytokines alter production of HIV-1 from primary mononuclear phagocytes.

Y Koyanagi1, W A O'Brien, J Q Zhao, D W Golde, J C Gasson, I S Chen.   

Abstract

Some strains of human immunodeficiency virus type 1 (HIV-1) can infect primary monocytes and monocyte-derived macrophages in vitro. In this report, the effect of cytokines on the production of one of these strains that shows a tropism for mononuclear phagocytes, designated HIV-1JR-FL, was studied. Primary peripheral blood mononuclear phagocytes infected with HIV-1JR-FL were treated with the hematopoietic factors: granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), macrophage colony-stimulating factor (M-CSF), and gamma-interferon (gamma-IFN). The M-CSF, GM-CSF, IL-3, and gamma-IFN were able to alter HIV-1 production under different conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3047875     DOI: 10.1126/science.3047875

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  115 in total

1.  Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation.

Authors:  Dafna Bonneh-Barkay; Stephanie J Bissel; Julia Kofler; Adam Starkey; Guoji Wang; Clayton A Wiley
Journal:  Brain Pathol       Date:  2011-12-22       Impact factor: 6.508

2.  Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region.

Authors:  Michaela Mack; Klaus Bender; Peter M Schneider
Journal:  Immunogenetics       Date:  2004-08-12       Impact factor: 2.846

3.  Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission.

Authors:  Surender B Kumar; Cara E Rice; Danny A Milner; Nilsa C Ramirez; William E Ackerman; Victor Mwapasa; Abigail Norris Turner; Jesse J Kwiek
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

4.  Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups.

Authors:  M T Dittmar; G Simmons; S Hibbitts; M O'Hare; S Louisirirotchanakul; S Beddows; J Weber; P R Clapham; R A Weiss
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Quantification of HIV by PCR in monocytes and lymphocytes in patients receiving antiviral treatment and low dose recombinant human granulocyte macrophage colony stimulating factor.

Authors:  F D Davison; R S Kaczmarski; A Pozniak; G J Mufti; S Sutherland
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

6.  Randomized, double-blind, placebo-controlled trial of the immune modulator WF10 in patients with advanced AIDS.

Authors:  S P Raffanti; W Schaffner; C F Federspiel; R B Blackwell; O A Ching; F W Kühne
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

7.  Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.

Authors:  O M Howard; K A Clouse; C Smith; R G Goodwin; W L Farrar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells.

Authors:  A Vyakarnam; P M Matear; S J Martin; M Wagstaff
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

9.  Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes.

Authors:  S Sonza; A Maerz; N Deacon; J Meanger; J Mills; S Crowe
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Contact with thymic epithelial cells as a prerequisite for cytokine-enhanced human immunodeficiency virus type 1 replication in thymocytes.

Authors:  M Rothe; L Chêne; M T Nugeyre; J Braun; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.